Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up COVID-19: Information for Patients and Caregivers We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.What you need to know 460 News Items found In the Clinic CAR Therapy for Solid Tumors Draws Attention at Annual Cancer Conference Sunday, March 31, 2019 Results from a clinical trial indicate that an experimental CAR therapy for mesothelioma is safe. Super Vision: How New Imaging Technologies Are Transforming Biomedical Research Wednesday, May 26, 2021 With the power of advanced microscopes, Sloan Kettering Institutes scientists are pushing the boundaries of what can be seen and measured. In the Lab More Evidence that Cellular ‘Death by Iron’ Could Be Promising Avenue of Cancer Treatment Monday, November 23, 2020 Cancers with certain mutations are vulnerable to ferroptosis, a form of iron-dependent cell death. In the Lab Origin Story: Finding on Macrophage Development Challenges Long-Held View Thursday, September 8, 2016 A surprising finding challenges long-held dogma about how certain immune cells develop into specialized types in diverse tissues. In the Clinic No Scalpel Required: Targeting Liver Tumors with Interventional Radiology Tuesday, October 27, 2020 Interventional radiology uses minimally invasive procedures that can treat some liver tumors as effectively as surgery. Treating Rare Cancers Friday, April 1, 2011 Memorial Sloan Kettering physicians have experience and specialized expertise in caring for people with uncommon cancers. At AACR, MSK Researchers Spotlight Health Disparities and Propose Solutions Wednesday, April 13, 2022 Topics included more diverse representation in clinical trials, racial disparities in colorectal cancer, and ancestry testing to improve diagnoses. Feature How a Chicken Helped Solve the Mystery of Cancer Wednesday, December 27, 2017 When this feathered patient found her way into a New York laboratory in 1909, she changed the course of cancer science. Feature First Targeted Cancer Drug Approved Based on Mutation Rather than Tumor Type Monday, November 26, 2018 Learn about larotrectinib, the first cancer drug to be FDA approved for adult and pediatric patients at the same time. Fasting Primes the Immune System’s Natural Killer Cells to Better Fight Cancer, New Study in Mice Finds Friday, June 14, 2024 Animal model research from MSK has shown for the first time that fasting can reprogram the metabolism of natural killer cells, helping them to survive in the harsh environment in and around tumors, while also improving their cancer-fighting ability. Pagination Load More Book traversal links for Newsroom Previous Newsroom Next Cody's Story: How the MSK Kids Rare Tumor Program Benefited a Teenager With Advanced Kidney Cancer